Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
122.8 USD | -1.00% | -7.76% | -2.50% |
May. 16 | Morgan Stanley Adjusts Ascendis Pharma Price Target to $140 From $116, Maintains Equal Weight Rating | MT |
May. 14 | US Equity Markets Close Higher Tuesday as Producer Prices Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.50% | 7.04B | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.26% | 22.28B | |
-11.90% | 22.41B | |
-5.71% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Wedbush Raises Price Target on Ascendis Pharma to $207 From $202, Maintains Outperform Rating